It is a human toxic-infection caused by the presence in the intestine of vibrio cholerae. It is an acute infectious disease of the small intestine, caused by the bacterium vibrio cholera and characterized by profuse watery diarrhea, vomiting, muscle cramps, severe dehydration, and depletion of electrolytes. Vibrio cholerae is a Gram-negative, comma shaped rod, which is motile with a single terminal flagellum.
DIARRHOEA IS LEADING CAUSE OF MORTALITY IN INDIA AS WELL AS GLOBALLY .THIS IS NICE PPT BASED ON WHO GUIDELINES,DIARRHOEA IS EASY TO TREAT BUT STILL IT IS IS 2ND MOST COMMON CAUSE OF CHILDHOOD MORTALITY AFTER PNEUMONIA
DIARRHOEA IS LEADING CAUSE OF MORTALITY IN INDIA AS WELL AS GLOBALLY .THIS IS NICE PPT BASED ON WHO GUIDELINES,DIARRHOEA IS EASY TO TREAT BUT STILL IT IS IS 2ND MOST COMMON CAUSE OF CHILDHOOD MORTALITY AFTER PNEUMONIA
WHO and UNICEF recommended management of Childhood Diarrhoea.
HLFPPT has been implementing Childhood Diarrhea management programmes with UNICEF and Micronutrient Initiative.
drugs that are used in diarrhea are explained in the ppt the drugs are explained according to their use and according to the pharmacological classification all drugs are brief by Dr. Mrunal Akre
Recurrent diarrhea is associated with many a number of complications. Out of them dehydration,malnutrition ,failure to thrive, electrolyte imbalances, micro nutrient deficiencies (vitamins & minerals) and severe systemic infections. Here an extensive description is given about these and the relevant management facts are given then and there.
WHO and UNICEF recommended management of Childhood Diarrhoea.
HLFPPT has been implementing Childhood Diarrhea management programmes with UNICEF and Micronutrient Initiative.
drugs that are used in diarrhea are explained in the ppt the drugs are explained according to their use and according to the pharmacological classification all drugs are brief by Dr. Mrunal Akre
Recurrent diarrhea is associated with many a number of complications. Out of them dehydration,malnutrition ,failure to thrive, electrolyte imbalances, micro nutrient deficiencies (vitamins & minerals) and severe systemic infections. Here an extensive description is given about these and the relevant management facts are given then and there.
A bunch of topic were selected for our subject Communicable Diseases, surprisingly I picked up "Cholera El tor"...
I have done enough research regarding this topic from Brunner and Suddarths MedSurg books and other resources. I collated the ideas and came up to this presentation...
Hope it will be able to help my colleagues, students and those people who needs to know the what, why's, and how of Cholera!
xoxo ^___^
This is a summary on the causes of diarrhea diseases in children, it gives also an approach to assessment and classification.as well as appropriate management of dehydration in such patients.
Diarrhea and vomiting in children
Vomiting (throwing up) and diarrhea (frequent, watery bowel movements) can be caused by viruses, bacteria, parasites, foods that are hard to digest (such as too many sweets) and other things.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
2. 1.Gastro intestinal infection Due
vibrio cholera
1.1 Introduction
It is a human toxic-infection caused by the presence in the intestine of
vibrio cholerae. It is an acute infectious disease of the small intestine,
caused by the bacterium vibrio cholera and characterized by profuse
watery diarrhea, vomiting, muscle cramps, severe dehydration, and
depletion of electrolytes. Vibrio cholerae is a Gram-negative, comma
shaped rod, which is motile with a single terminal flagellum.
3. 2. Pathophysiology
V cholerae is
comma-shaped,
gram-negative aerobic or facultative anaerobic bacillus
bacillus that varies in size from 1-3 Aμm in length by 0.5-0.8 Aμm in
diameter
Its antigenic structure consists of
flagellar H antigen
somatic O antigen.
7. 4. Transmission
A person can get cholera by drinking water or eating food
contaminated with cholera bacteria. In an epidemic, the source of the
contamination is usually the feces of an infected person that
contaminates water or food. The disease can spread rapidly in areas
with inadequate treatment of sewage and drinking water.
8. 5. Incubation
Ranges from a few hours to 5 days, Average is 1-3 days Shorter
incubation period High gastric pH (from use of antacids), Consumption
of high dosage of cholera.
9. 6. Risk factor
Age: Children: 10x more susceptible than adults, And Elderly also
higher susceptible.
Sex: Equal in both male and female.
Immunity: Less immune higher risk.
People with low gastric acid levels
10. Other RISK FACTORS
Poor sanitary conditions: Rare in developed countries and Common
in Asia, Africa, & Latin America
undercooked food: Contaminated seafood, even in developed
countries Especially shellfish.
Hypochlorhydria: People with low levels of stomach acid Such as
children, older adults, and some medications.
11. 7. Signs and symptoms
watery diarrhea (more than 20-50 times / day) without abdominal
pain
stool is very liquid
looking like “rice water” very frequent
abundant vomiting without effort and nausea, vomit of "rice water
“appearance.
13. Diarrhea and vomiting lead to significant dehydration with painful
muscle cramps, the hydro -electrolytic disorders are severe and the
patient is often in acidosis and hypokalemia.
There is also oliguria or anuria (hypovolemic shock + acute renal
failure).
Ultimately the patient falls into a state of algidity: Cold extremities,
severe hypotension, hypothermia, rapid pulse, persistent skin folds.
14. 8. DIAGNOSIS
A. Clinical evaluation of dehydration
Mild dehydration : 3 - 5% loss of body weight
(Plan A)
No signs of dehydration
15. Moderate dehydration : 6-9% loss of
body weight
(Plan B)
Able to drink plus 2 or more of the following:
Sunken Eyes and / or Skin pinch 1 - 2 seconds
Restlessness / Irritability
16. Severe dehydration : 10-15% loss of
body weight
(Plan C)
Pulse fine but unable to drink plus:
Sunken Eyes
very slow Skin pinch ≥ 2 seconds
sensorium abnormally sleepy or lethargic
drinking poorly or not at all
18. 9. Nursing intervention
Discus with patient the importance of fluid replacement during
diarrheal episodes.
Teach patient the importance of good perianal hygiene
Give drugs as prescribed
19. 10. More detailed guidelines for the
treatment of cholera are as follows:
1. Evaluate the degree of dehydration upon arrival
2. Rehydrate the patient
3. Register output and intake volumes on predesigned charts and
periodically review these data.
4. Treat the causes
20. 11. Treatment
A. REHYDRATION
If dehydration and shock give appropriate treatment as follows:
Consider ABC
20ml/kg of normal saline (NS) or Ringers Lactate(RL) as quickly as
possible IV in 15 minutes
Repeat the bolus of NS or RL 3-4 times if persistence of Signs of shock
Treat as severe dehydration after correction of shock
21. If severe dehydration without shock
(Plan C)
Ringers Lactate /N.S Age < 12 months
Step 1 : 30 mls / kg over 1 hour
Step 2 :70 mls / kg over 5 hours
Ringers Lactate /N.S Age ≥ 12 months to 5years
Step 1: 30 mls / kg over 30 mins
Step 2 : 70 mls / kg over 2.5 hours
Then re-assess child, if signs of severe dehydration persists repeat step 2. If signs improve
treat for moderate dehydration
22. If moderate dehydration (Plan B):
Give ORS 75ml/kg during 4 hours
After 4 hours: Reassess the child and classify the child for
dehydration
Select the appropriate plan to continue treatment
Begin feeding the child in clinic
23. If no dehydration (Plan A):
Treat the child as an outpatient; give ORS 10ml/kg after each watery
stool.
24. B. ANTIMICROBIAL THERAPY
Adults
Doxycycline, 300 mg po single dose, Ciprofloxacin, 1g po single dose OR
Azithromycin 1g po single dose.
Pregnant
Erythromycin 500 mg/ 6 hours for 3 days OR azithromycin, 1g po single dose
Children> 3yrs
Erythromycin 12.5mg/kg/ 6 hours for 3dys OR azithromycin 20 mg/kg, in a single
dose, without exceeding 1 g
Children < 3yrs
Erythromycin 12.5mg/kg/ 6 hours for 3dys OR azithromycin 20 mg/kg, in a single
dose